MET and neoplasm: Furthermore, potent c-Met inhibitors like crizotinib or cabozantinib were not used in this study, which might have provided insights into their feasibility to preclude metastatic behavior in particular in tumor cells showing high c-MET expression and concomitant high invasiveness.